Consumers Report Quality of Life Improvements From Medical Cannabis Use

Patients prescribed medical cannabis products overwhelmingly report improvements in their health-related quality of life, according to survey data compiled by the medical cannabis provider Releaf.

Researchers surveyed 1,669 adults medically authorized to consume cannabis. British health care providers may prescribe cannabis-based medicinal products to patients who are unresponsive to conventional medications. Most respondents suffered from either chronic pain or mental health issues. Respondents primarily consumed herbal cannabis, with about one-third of patients consuming CBD-dominant formulations.

Prior to consuming cannabis, 68 percent of respondents reported that their quality of life was “significantly impaired.” Following cannabis therapy, 88 percent reported “improved or significantly improved” quality of life. Furthermore:

• 97% of patients report improved quality of life
• 78% rate their treatment as ‘extremely effective’ or ‘very effective’
• 88% have not experienced any side effects
• 91% were likely to recommend medical cannabis to others who may be eligible
• 72% have been prescribed medical cannabis to treat more than one condition

“This comprehensive survey of 1,669 active medical cannabis patients represents the largest study of prescribed medical cannabis users in the UK to date,” the study’s authors concluded. “The findings reveal a patient population experiencing transformative benefits from their treatment.”